581 related articles for article (PubMed ID: 24612702)
1. Survival benefits of postoperative chemoradiation for lymph node-positive esophageal squamous cell carcinoma.
Hsu PK; Huang CS; Wang BY; Wu YC; Hsu WH
Ann Thorac Surg; 2014 May; 97(5):1734-41. PubMed ID: 24612702
[TBL] [Abstract][Full Text] [Related]
2. Distant nodal metastases from intrathoracic esophageal squamous cell carcinoma: characteristics of long-term survivors after chemoradiotherapy.
Chao YK; Wu YC; Liu YH; Tseng CK; Chang HK; Hsieh MJ; Chu Y; Liu HP
J Surg Oncol; 2010 Aug; 102(2):158-62. PubMed ID: 20648587
[TBL] [Abstract][Full Text] [Related]
3. Lymph node harvest in esophageal cancer after neoadjuvant chemoradiotherapy.
Shridhar R; Hoffe SE; Almhanna K; Weber JM; Chuong MD; Karl RC; Meredith K
Ann Surg Oncol; 2013 Sep; 20(9):3038-43. PubMed ID: 23625142
[TBL] [Abstract][Full Text] [Related]
4. Postoperative Adjuvant Therapy Improves Survival in Pathologic Nonresponders After Neoadjuvant Chemoradiation for Esophageal Squamous Cell Carcinoma: A Propensity-Matched Analysis.
Hsu HY; Chao YK; Hsieh CH; Wen YW; Chang HK; Tseng CK; Liu YH
Ann Thorac Surg; 2016 Nov; 102(5):1687-1693. PubMed ID: 27457831
[TBL] [Abstract][Full Text] [Related]
5. Pre- versus postoperative chemoradiotherapy for locally advanced esophageal squamous cell carcinoma.
Hsu PK; Chen HS; Liu CC; Huang CS; Hsieh CC; Hsu HS; Wu SC
J Thorac Cardiovasc Surg; 2017 Aug; 154(2):732-740.e2. PubMed ID: 28457536
[TBL] [Abstract][Full Text] [Related]
6. Pathologic nonresponders after neoadjuvant chemoradiation for esophageal cancer demonstrate no survival benefit compared with patients treated with primary esophagectomy.
Dittrick GW; Weber JM; Shridhar R; Hoffe S; Melis M; Almhanna K; Barthel J; McLoughlin J; Karl RC; Meredith KL
Ann Surg Oncol; 2012 May; 19(5):1678-84. PubMed ID: 22045465
[TBL] [Abstract][Full Text] [Related]
7. Postoperative radiation therapy with or without concurrent chemotherapy for node-positive thoracic esophageal squamous cell carcinoma.
Chen J; Pan J; Liu J; Li J; Zhu K; Zheng X; Chen M; Chen M; Liao Z
Int J Radiat Oncol Biol Phys; 2013 Jul; 86(4):671-7. PubMed ID: 23773390
[TBL] [Abstract][Full Text] [Related]
8. Predictors of long-term survival after resection of esophageal carcinoma with nonregional nodal metastases.
Lee PC; Port JL; Paul S; Stiles BM; Altorki NK
Ann Thorac Surg; 2009 Jul; 88(1):186-92; discussion 192-3. PubMed ID: 19559222
[TBL] [Abstract][Full Text] [Related]
9. The role of surgery and postoperative chemoradiation therapy in patients with lymph node positive esophageal carcinoma.
Bédard EL; Inculet RI; Malthaner RA; Brecevic E; Vincent M; Dar R
Cancer; 2001 Jun; 91(12):2423-30. PubMed ID: 11413534
[TBL] [Abstract][Full Text] [Related]
10. Comparison between radical esophagectomy and definitive chemoradiotherapy in patients with clinical T1bN0M0 esophageal cancer.
Motoori M; Yano M; Ishihara R; Yamamoto S; Kawaguchi Y; Tanaka K; Kishi K; Miyashiro I; Fujiwara Y; Shingai T; Noura S; Ohue M; Ohigashi H; Nakamura S; Ishikawa O
Ann Surg Oncol; 2012 Jul; 19(7):2135-41. PubMed ID: 22302264
[TBL] [Abstract][Full Text] [Related]
11. Retrospective analysis of outcome differences in preoperative concurrent chemoradiation with or without elective nodal irradiation for esophageal squamous cell carcinoma.
Hsu FM; Lee JM; Huang PM; Lin CC; Hsu CH; Tsai YC; Lee YC; Chia-Hsien Cheng J
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e593-9. PubMed ID: 21658851
[TBL] [Abstract][Full Text] [Related]
12. Do We Need to Add Postoperative Radiotherapy in Patients Undergoing Trimodality Therapy for Esophageal Squamous Cell Carcinoma with Positive Lymph Nodes Disease?
Huang PM; Hsu FM; Lin CC; Hsu CH; Cheng JC; Lee JM
Dig Surg; 2018; 35(2):104-110. PubMed ID: 28675905
[TBL] [Abstract][Full Text] [Related]
13. Different recurrence pattern after neoadjuvant chemoradiotherapy compared to surgery alone in esophageal cancer patients.
Smit JK; Güler S; Beukema JC; Mul VE; Burgerhof JG; Hospers GA; Plukker JT
Ann Surg Oncol; 2013 Nov; 20(12):4008-15. PubMed ID: 23838922
[TBL] [Abstract][Full Text] [Related]
14. Oncologic Outcomes According to Remnant Lymph Node Metastases in Pathologic T0 (ypT0) Esophageal Squamous Cell Carcinoma Following Prospective Neoadjuvant Therapy and Surgery.
Cho HJ; Kim YH; Kim HR; Kim DK; Park SI; Kim JH; Kim SB
Ann Surg Oncol; 2015; 22(6):1851-7. PubMed ID: 25344308
[TBL] [Abstract][Full Text] [Related]
15. Concurrent chemoradiotherapy with or without surgery for patients with resectable esophageal cancer: An analysis of the National Cancer Data Base.
Naik KB; Liu Y; Goodman M; Gillespie TW; Pickens A; Force SD; Steuer CE; Owonikoko TK; Ramalingam SS; Higgins K; Beitler JJ; Shin DM; Willingham FF; El-Rayes B; Landry JC; Fernandez FG; Saba NF
Cancer; 2017 Sep; 123(18):3476-3485. PubMed ID: 28464264
[TBL] [Abstract][Full Text] [Related]
16. Definitive or Preoperative Chemoradiation Therapy for Esophageal Cancer: Patterns of Care and Survival Outcomes.
Shao MS; Wong AT; Schwartz D; Weiner JP; Schreiber D
Ann Thorac Surg; 2016 Jun; 101(6):2148-54. PubMed ID: 27016842
[TBL] [Abstract][Full Text] [Related]
17. A Propensity-matched Analysis Comparing Survival After Esophagectomy Followed by Adjuvant Chemoradiation to Surgery Alone for Esophageal Squamous Cell Carcinoma.
Hwang JY; Chen HS; Hsu PK; Chao YK; Wang BY; Huang CS; Liu CC; Wu SC
Ann Surg; 2016 Jul; 264(1):100-6. PubMed ID: 26649580
[TBL] [Abstract][Full Text] [Related]
18. REG1A expression status suggests chemosensitivity among advanced thoracic esophageal squamous cell carcinoma patients treated with esophagectomy followed by adjuvant chemotherapy.
Sato Y; Motoyama S; Nanjo H; Ito S; Yoshino K; Sasaki T; Kuribayashi K; Nagaki Y; Imai K; Saito H; Minamiya Y; Ogawa J
Ann Surg Oncol; 2013 Sep; 20(9):3044-51. PubMed ID: 23645481
[TBL] [Abstract][Full Text] [Related]
19. Lymph node dissection after chemoradiation in esophageal cancer: a subgroup analysis of patients with and without pathological response.
Chao YK; Liu HP; Hsieh MJ; Wu YC; Liu YH; Yeh CH; Chang HK; Tseng CK
Ann Surg Oncol; 2012 Oct; 19(11):3500-5. PubMed ID: 22622470
[TBL] [Abstract][Full Text] [Related]
20. Significant invasion of the pharyngeal constrictor muscle in early squamous cell carcinoma of the tonsil: prediction of multiple regional metastasis.
Park JO; Lee YS; Joo YH; Nam IC; Cho KJ; Cho JH; Kim MS
Arch Otolaryngol Head Neck Surg; 2012 Nov; 138(11):1034-9. PubMed ID: 23165377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]